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Summary
BACKGROUND: On 1 January 2012 Swiss Diagnosis
Related Groups (DRG), a new uniform payment system
for in-patients was introduced in Switzerland with the in-
tention to replace a “cost-based” with a “case-based” re-
imbursement system to increase efficiency. With the in-
troduction of the new payment system we aim to answer
questions raised regarding length of stay as well as pa-
tients’ outcome and satisfaction.
METHODS: This is a prospective, two-centre observation-
al cohort study with data from University Hospital Basel
and the Cantonal Hospital Aarau, Switzerland, from Janu-
ary to June 2011 and 2012, respectively. Consecutive in-
patients with the main diagnosis of either community-ac-
quired pneumonia, exacerbation of COPD, acute heart fail-
ure or hip fracture were included. A questionnaire survey
was sent out after discharge investigating changes before
and after SwissDRG implementation. Our primary end-
point was LOS.
RESULTS: Of 1,983 eligible patients 841 returned the
questionnaire and were included into the analysis (429 in
2011, 412 in 2012). The median age was 76.7 years (50.8%
male). Patients in the two years were well balanced in re-
gard to main diagnoses and co-morbidities. Mean LOS in
the overall patient population was 10.0 days and compar-
able between the 2011 cohort and the 2012 cohort (9.7 vs
10.3; p = 0.43). Overall satisfaction with care changed only
slightly after introduction of SwissDRG and remained high
(89.0% vs 87.8%; p = 0.429).
DISCUSSION: Investigating the influence of the imple-
mentation of SwissDRG in 2012 regarding LOS patients’
outcome and satisfaction, we found no significant changes.
However, we observed some noteworthy trends, which
should be monitored closely.
Key words: DRG; SwissDRG; length of stay; outcome;
fee-for-service; quality of care; internal medicine;
surgery; Cantonal Hospital Aarau; Basel University
Hospital; Basel University
Background
On 1 January 2012 a new uniform case-based payment sys-
tem for inpatients was introduced in Switzerland in order to
decrease the costs for medical treatment mainly by shorten-
ing length of stay (LOS) and optimising efficiency [1–4].
Due to the consistently rising health care costs such a re-
form was strongly encouraged by politics [5, 6]. Anoth-
er goal was better transparency regarding reimbursement
to get a better comparability and thereby increases in ef-
ficiency [7]. The SwissDRG system is a flat rate system.
DRG stands for diagnoses related groups. Several dia-
gnoses are collected in preferably homogeneous groups
containing patients with similar age, sex, diagnoses, co-
morbidities, complications and treatment. For each of these
groups a fixed remuneration for in-patients is defined [8].
Before 2012 various reimbursement systems were applied
in different states (cantons) within Switzerland. Some can-
tons applied the fee-for-service (FFS) based system remu-
nerating single medical services on top of a daily fee. Other
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cantons applied a precursor of the current Swiss DRG sys-
tem, the all patient (AP-) DRG system.
The DRG system was developed at Yale University in the
1970’s. Since then many adaptations were developed in
several countries all over the world. The SwissDRG is
based on the German (G-) DRG, which has its roots in the
Australian refined (AR-) DRG. The AR-DRG was derived
from the AP-DRG [8].
Before the introduction of SwissDRG some concerns were
raised among physicians regarding possible decreases in
the quality of care [3, 9]. The main concerns were so-
called “bloody exits”, the premature discharging of patients
leading to a high re-hospitalisation rate. This concern was
raised in literature mostly from the United States during the
1980’s, but also in newer reports from Germany [1, 2, 10].
Furthermore, patient satisfaction with the treatment and the
discharge was expected to decrease.
To investigate these concerns we compared the clinical out-
come and the patients’ satisfaction before and after the
introduction of SwissDRG in two tertiary hospitals in
Switzerland, the University Hospital Basel (USB) and the
Cantonal Hospital Aarau (KSA). These two hospitals are
located in different cantons, which initially (up to 2012)
had two different reimbursement systems (FFS and AP-
DRG, respectively).
In an earlier study in 2011, we compared the FFS hospital
USB and the AP-DRG hospital KSA regarding LOS and
patients’ outcome before 2012 [11]. The investigation
showed a shorter LOS in the AP-DRG hospital. However,
this result did not remain significant after multivariate ad-
justment. The re-hospitalisation rate was significantly
higher in the FFS hospital before and after adjustments,
which may have resulted from the higher co-morbidity load
in the FFS hospital (higher prevalence of diabetes and renal
failure).
The aim of the current study was to investigate the influen-
ce of the implementation of the SwissDRG in 2012 regard-
ing LOS, patients’ outcome and satisfaction. According to
our knowledge and literature search, no newer studies have
been performed addressing these goals after the introduc-
tion of SwissDRG.
Methods
Study design, centres and setting
This is a prospective, two centre observational cohort study
using a survey with patients discharged from the University
Hospital Basel and the Cantonal Hospital Aarau in north-
western Switzerland. The postal mail survey took place
between January and June 2011 and January and June
2012. The University Hospital of Basel is a tertiary referral
centre with 670 beds treating around 31,600 hospitalised
patients a year. Until the end of 2011 a fee-for-service
based reimbursement system was in place at this hospital.
From 1 January 2012 onwards the reimbursement system
was changed to SwissDRG in the whole of Switzerland.
The Cantonal Hospital Aarau is also a tertiary university-
affiliated hospital with 630 beds treating roughly 26,700
hospitalised patients per year. As opposed to Basel, this
hospital used the AP-DRG reimbursement system up to the
end of 2011 switching to the SwissDRG at the same time
as the University Hospital Basel.
The two local ethical committees approved the study pro-
tocol.
Selection of participants and procedures
All patients hospitalised between January and June 2011
and 2012 with the International Code of Disease (ICD-10)
diagnosis of a community-acquired pneumonia (CAP;
ICD-10 codes J10.0, J12–18), acute heart failure (AHF;
ICD-10 code I50), exacerbation of chronic obstructive pul-
monary disease (COPD; ICD-10 code J44.1) or hip fracture
(ICD-10 codes S72.0–1) were included in our study. We
chose these diagnostic groups because they represent im-
portant and well-defined patient cohorts within the medical
and surgical spectrum. 2–4 months after hospital discharge
they received a questionnaire by postal mail. A second
mailing was sent to non-responders.
Patients who died during the hospitalisation or were under
the age of 16 years were excluded. Patients hospitalised
several times at the same study centre during the same
study period in 2011 or 2012 were analysed on first admis-
sion and excluded in all further admissions because of po-
tential recall bias.
Endpoints and Outcomes
Our primary endpoint was to analyse, whether the change
in reimbursement systems between 2011 (pre-cohort) and
2012 (post-cohort) was associated with a change in LOS.
LOS is defined as the time frame between the admission
and the discharge from hospital. Secondary endpoints were
patients’ satisfaction regarding care in general as well as
the discharge process, the re-hospitalisation rate, the ad-
mission to a rehabilitation institution and health-related
quality of life. Furthermore, visits to the general practition-
er concerning the hospitalisation were of interest.
Overall satisfaction with the hospitalisation was determin-
ed by a scale from 0% (very bad) to 100% (very good).
The definition of re-hospitalisation was the admission to a
hospital in the first 3 months after the primary hospitalisa-
tion. Quality of life was using modified questions from the
EQ-5D questionnaire with the dimensions mobility, self-
care, usual activities, pain/discomfort and anxiety/depres-
sion (see questionnaire in Appendix 1).
Statistics
We used mean and standard deviation or median and in-
terquartile range as appropriate to describe the population.
Because LOS is a heavily skewed outcome, simple linear
regression models are not appropriate. We therefore com-
pared differences between LOS by fitting a generalised
linear model (GLM) using gamma distribution and log
link function as recommended [12]. LOS was compared
between the two cohorts overall, and within different sub-
groups (e.g., main medical diagnosis, study centre). To
deal with potential confounding between the pre-cohort
and post-cohort, we adjusted all models for the main pre-
dictors of LOS namely age, gender, diagnosis and the most
important co-morbidities (anaemia, congestive heart fail-
ure, COPD, diabetes, hypertension, coronary heart disease,
renal insufficiency, malignancy, history of trauma). For
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secondary endpoints, similar linear regression models were
used for the continuous, normally distributed data and lo-
gistic models for binary data.
Reported confidence intervals are two-sided 95% intervals
and tests were performed at the two-sided 5% significance
level. All analyses were performed with STATA 12.1 (Stata
Corp, College Station, Texas).
When mentioning a “trend” we refer to a p between >0.05
and <0.20.
Results
Figure 1
Patient inclusion flow chart 2011.
Baseline characteristics
1983 patients (2011 n = 1,047, 2012 n = 936) of the two
study centres met the inclusion requirements. A letter and
questionnaire were sent to 1,657 patients (83.6%) after ex-
clusion of non-survivors. 29.2% (n = 578) returned the
complete questionnaire and after a second send-out the
number of responders rose to 42.41% (n = 841). These
841 patients (= 100%; 429 (41%) in 2011 and 412 in 2012
(44%) were included in the study (see inclusion flow charts
in figures 1 and 2). 78.6% (n = 661) of the questionnaires
were fully completed; in 13.4% (n = 113) one question and
in 8.0% (n = 67) two or more questions were missing. The
most common main diagnosis was CAP with 34.5% (n =
290) followed by AHF in 32.2% (n = 271; see table 1). Hip
Figure 2
Patient inclusion flow chart 2012.
Table 1: Baseline characteristics of included patients according to time period.
Overall 2011 2012 p-value
(n = 841) (n = 429) (n = 412)
Sociodemographics
Age, median (IQR)* 76.7 (66, 83.1) 77 (66.7, 83.6) 76 (66, 83) 0.250
Male gender 50.8% (n = 427) 47.8% (n = 205) 53.9% (n = 222) 0.077
Study centres
(Former) AP-DRG 32.8% (n = 276) 36.1% (n = 155) 29.4% (n = 121)
(Former) FFS 67.2% (n = 565) 63.9% (n = 274) 70.6% (n = 291)
0.037
Main diagnosis
Acute heart failure 32.22% (n = 271) 33.80% (n = 145) 30.58% (n = 126)
Community-acquired pneumonia 34.48% (n = 290 ) 34.03% (n = 146 ) 34.95% (n = 144 )
Acute exacerbation of COPD** 14.27% (n = 120 ) 11.89% (n = 51) 16.75% (n = 69)
Hip fracture 19.02% (n = 160 ) 20.28% (n = 87) 17.72% (n = 73 )
0.177
Co-morbidities
Any co-morbidities 45.5% (n = 383) 45% (n = 193) 46.1% (n = 190) 0.743
Renal failure 10.3% (n = 87) 9.1% (n = 39) 11.7% (n = 48) 0.223
Malignancy 2.7% (n = 23) 2.8% (n = 12) 2.7% (n = 11) 0.910
Gastrointestinal disease 4.3% (n = 36) 4.4% (n = 19) 4.1% (n = 17) 0.828
COPD 17.8% (n = 150) 16.3% (n = 70) 19.4% (n = 80) 0.240
Diabetes type II 8.4% (n = 71) 7.7% (n = 33) 9.2% (n = 38) 0.425
Hypertension 15.0% (n = 126) 16.3% (n = 70) 13.6% (n = 56) 0.268
Coronary heart disease 16.1% (n = 135) 16.6% (n = 71) 15.5% (n = 64) 0.688
Congestive heart failure 10.7% (n = 90) 10.7% (n = 46) 10.7% (n = 44) 0.984
Other cardiac diseases 19.9% (n = 167) 21.2% (n = 91) 18.5% (n = 76) 0.315
History of stroke 5.4% (n = 45) 5.8% (n = 25) 4.9% (n = 20) 0.531
Other neurological diseases 4.6% (n = 39) 3.7% (n = 16) 5.6% (n = 23) 0.201
Anaemia 4.8% (n = 40) 5.6% (n = 24) 3.9% (n = 16) 0.244
History of fracture or trauma 7.3% (n = 61) 9.3% (n = 40) 5.1% (n = 21) 0.018
* p-value refer to Mann-Whitney-U and chi-square tests ** chronic obstructive pulmonary disease
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fracture was present in a smaller group of 19.0% (n = 160)
and acute exacerbation of COPD was the least frequent
main diagnosis with 14.3% (n = 120). The overall median
patient age was 76.7 years, which was similar in both time
periods (p = 0.25). 50.8% (n = 427) of patients were male
with a higher proportion in the second time period (47.8%,
n = 205 in 2011 vs. 53.9%, n = 222 in 2012; p = 0.077).
The occurrence of the four main diagnoses did not show
a statistical significant difference between 2011 and 2012.
Almost half (45.5%, n = 383) of patients were suffering
from at least one comorbidity. Taken both years together,
the most frequently represented co-morbidities were coron-
ary heart disease with 16.1% (n = 135), hypertension (15%,
n = 126), congestive heart failure with 10.7% (n = 90) and
renal insufficiency (10.3%, n = 87). The four co-morbidit-
ies hypertension, coronary heart disease, congestive heart
failure and history of stroke were similarly represented in
both time periods. Congestive heart failure showed by far
the smallest difference between 2011 and 2012 (p = 0.984).
These above mentioned four co-morbidities belong to the
group of cardiovascular diseases, the main cause of death
in Switzerland according to Swiss Federal Statistical Of-
fice (BFS) [13]. Also, the second most common cause of
death, namely malignancy showed an almost identical pre-
valence within the two time periods (p = 0.910). The men-
tioned similarities between the two cohorts of 2011 and
2012 regarding co-morbidities point to the comparability of
the two data sets. The largest difference between 2011 and
2012 was found regarding the prevalence of the co-mor-
bidity “history of fracture or trauma”, which was higher in
2011 than in 2012 (p = 0.018). Co-morbidities occurring in
less than 20 patients are not listed in the tables.
Primary and secondary outcomes
Length of hospital stay
Mean LOS in the overall patient population was 10.0 days
(95%CI 9.4, 10.6). Overall, LOS was not different between
the 2011 and the 2012 cohorts (9.7 days vs 10.3 days, p =
0.43). This was also true for the subgroups of patients with
CAP, AHF and hip fracture, where no differences in LOS
was observed after the introduction of SwissDRG. In pa-
tients with acute exacerbation of COPD there was a trend
towards longer LOS without reaching statistical signific-
ance (p = 0.118). Table 2 shows detailed results for the
overall cohort and the four main diagnoses. The longest
LOS was found in hip fracture patients (11.5 days, 95%CI
9.7, 13.2) followed by acute exacerbation of COPD pa-
tients (10.9 days, 95%CI 8.8, 12.9), AHF patients (9.8
days, 95%CI 9.0, 10.6). CAP patients had the shortest LOS
of 9.0 days (95%CI 8.2, 9.8).
Patients who were discharged to a post-acute care facility
had a significantly longer LOS compared to patients dis-
charged home in the 2011 cohort (12.0 vs 8.9 days, p
<0.01) and the 2012 cohort (12.4 vs 9.2 days, p <0.01).
However, there was no difference in the frequency of post-
acute care facility relocation between the two time cohorts
(30.0% vs 32.4%, respectively, p = 0.40), which is a po-
tential confounder for our results. Also, there was no effect
modification on LOS difference between 2011 and 2012
by post-acute care facility relocation of our main statistical
model (p interaction term = 0.45).
Re-hospitalisation and satisfaction with care
The re-hospitalisation rate was similar in the two cohorts
(9.3%, n = 37) in 2011 and 11.6% in 2012 (n = 46, p =
0.317). Furthermore, similar rates of follow-ups were ob-
served at the general practitioners’ (GP, 60.6%, n = 260 in
2011 vs 62.4%, n = 257 in 2012; p = 0.392).
Overall satisfaction with care did not change much after
the introduction of SwissDRG and remained high (89.0%
in 2011 vs 87.8% in 2012; p = 0.429). The number of pa-
tients satisfied with the date of discharge was also similar
in 2011 and 2012 (88.6%, n = 380 vs 91.3%, n = 376; p =
0.299). However, there was a trend with more patients feel-
ing insecure on discharge in 2012 (23.1%, n = 99 vs 26.7%,
n = 110; p = 0.141).
Quality of life
Quality of life was assessed with a standardised question-
naire across five dimensions (EQ-5D, mobility, self-care,
usual activities, pain and depression). A high proportion of
patients reported problems with their mobility (48.2%, n
= 405), during usual activities (49.8%, n = 419) and with
pain or discomfort respectively (50.1%, n = 421). The num-
ber of patients experiencing problems with mobility, usual
activities and anxiety/depression stayed the same. Regard-
ing self-care as well as pain or discomfort there was no dif-
ference between 2011 to 2012, although there was a trend
towards more problems with self-care (p = 0.100) and more
pain or discomfort (p = 0.186).
Discussion
Overall, there were only few if any relevant changes, as
was to be expected due to the short time interval of one
year between the two cohorts. Nevertheless there were
some important early trends, which may forecast changes
in the future.
The two time cohorts were rather similar regarding co-mor-
bidities and therefore well balanced. Regarding baseline
characteristics only two significant differences were ap-
parent: There were significantly less patients with history
of fracture and trauma and a higher proportion of men in
2012. These differences may be explained by a changing
patient flow pattern due to the implementation of Swis-
sDRG and possibly changing demographics. To confirm
this assumption another study investigating the admission
flows to hospitals should follow.
The expectation was that LOS would decrease with the
implementation of the SwissDRG. The data in this study
show that LOS remains stable or even tends to increase
shortly after implementation of SwissDRG. The reason for
this trend can only be assumed and may be due to changes
in the patient transfer processes from acute to post-acute
care hospitals. This assumption is based on the fact that
the process of coverage confirmation by the insurer for
post-acute care facilities was changed with the implement-
ation of SwissDRG. The change of remuneration systems
to SwissDRG allows the insurer now to use eight working-
days’ time to decide regarding provision of cost coverage
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for post-acute care institutions. However, further studies
are necessary to identify the reasons for this development.
In 2003 the G-DRG was introduced in Germany [8].
Bartkowski et al. analysed the development of LOS in Ger-
many between 1994 and 2010. They observed a continu-
ously decreasing LOS. Particularly no significant change in
this trend after the implementation of the G-DRG was ob-
served [10]. However, as mentioned previously, the study
period after the DRG implementation was only six months.
Follow-up –studies are needed to verify a decrease in LOS
of hospitalised patients as would be expected in accordance
with the data from Germany.
The concerns about “bloody exits” meaning too early dis-
charge from hospitals did not become evident in this study.
Patients did not feel that they were discharged too early.
Furthermore, there was no significant increase in the num-
ber of visits to the GP’s office after DRG implementation.
However, although patients agreed with the time point of
discharge, there was still a noteworthy trend for these same
patients to feel more insecure, to have more problems with
self-care and more pain or discomfort. This may lead to
the assumption of too early discharge. Another explanation
may be that by the implementation of DRG sicker patients
with more co-morbidities are directed rather towards ter-
tiary care hospitals and less sick patients to peripheral in-
stitutions. To verify these assumptions and trends, further
research in this area and a longer follow-up of our cohort
should be conducted.
Our study has several limitations. First, it was a short study
period of six months after the nation-wide DRG-imple-
mentation. The time point chosen for the analysis is still
relevant in order not to miss early effects. It allowed us
to identify some important trends but may be too short to
draw final conclusions. Second, our study comprised two
centres in the northwestern part of Switzerland. Therefore,
the results may not be generalisable to other parts of the
country or other regions of the world the same is true for
the diagnoses used where our findings may not be the same
for other illnesses than the ones studied here. Interestingly
however, like in our study, the Swiss Federal Statistical Of-
fice (BFS) observed the same stable or even slightly in-
creasing LOS for all Swiss hospitals from 2011 to 2012
[14]. Third, patients with four defined main diagnoses were
included; other diagnoses may show different patterns re-
garding LOS and quality of care. However, we believe
that these four diagnoses represent an important part of pa-
Table 2: Primary and secondary endpoints with regard to time period.
Overall 2011 2012 Adjusted regression
coefficient or odds ratio†
p-value
(n = 841) (n = 429) (n = 412)
LOS**, [days], mean (CI)
All patients 9.99 (9.41, 10.58) 9.72 (9.00, 10.45) 10.27 (9.35, 11.20) Coefficient 0.05 (–0.07, 0.16) 0.430
Acute heart failure 9.81 (8.98, 10.64) 10.28 (9.03, 11.54) 9.26 (8.21, 10.31) Coefficient -0.12 (–0.28, 0.05) 0.171
Community-acquired pneumonia 8.99 (8.19, 9.79) 8.58 (7.32, 9.84) 9.40 (8.42, 10.38) Coefficient 0.07 (–0.11, 0.24) 0.463
Acute exacerbation of COPD*** 10.86 (8.83, 12.89) 9.22 (7.49, 10.94) 12.07 (8.76, 15.38) Coefficient 0.29 (–0.07, 0.65) 0.118
Hip fracture 11.48 (9.72, 13.24) 11.01 (9.29, 12.73) 12.04 (8.71, 15.37) Coefficient 0.03 (–0.25, 0.32) 0.822
(Former) AP-DRG 8.42 (7.77, 9.06) 8.46 (7.62, 9.29) 8.36 (7.33, 9.40) Coefficient 0.00 (–0.15, 0.15) 0.979
(Former) FFS 10.76 (9.96, 11.57) 10.44 (9.42, 11.47) 11.07 (9.84, 12.30) Coefficient 0.05 (–0.10, 0.20) 0.545
Re-hospitalisation rate 10.4% (n = 83) 9.3% (n = 37) 11.6% (n = 46) OR 1.27 (0.80, 2.03) 0.317
Rehabilitation after discharge 31.0% (n = 250) 29.7% (n = 121) 32.4% (n = 129) OR 1.24 (0.89, 1.72) 0.198
Follow-up by general practitioner 61.5% (n = 517) 60.6% (n = 260) 62.4% (n = 257) OR 1.13 (0.85, 1.51) 0.392
Overall satisfaction with care
(100%-0%), mean (SD)
88.4% (±15.92) 89.0% (±15.43) 87.8% (±16.43) Coefficient –0.90 (–3.13, 1.33) 0.429
Satisfaction with discharge procedure
Not satisfied with date of discharge 10.1% (n = 85) 11.4% (n = 49) 8.7% (n = 36) OR 0.78 (0.49, 1.24) 0.299
Too early 8.4% (n = 71) 9.6% (n = 41) 7.3% (n = 30) OR 0.79 (0.48, 1.30) 0.351
Too late 1.7% (n = 14) 1.9% (n = 8) 1.5% (n = 6) OR 0.75 (0.25, 2.25) 0.609
Feeling of insecurity at discharge 24.9% (n = 209) 23.1% (n = 99) 26.7% (n = 110) OR 1.27 (0.92, 1.76) 0.141
Insufficient informed about discharge 10.9% (n = 83) 12.8% (n = 49) 9.0% (n = 34) OR 0.67 (0.42, 1.08) 0.101
Not satisfied with date of information about
discharge
7.7% (n = 65) 8.9% (n = 38) 6.6% (n = 27) OR 0.73 (0.43, 1.23) 0.232
Too early 1.0% (n = 8) 1.2% (n = 5) 0.7% (n = 3) OR 0.59 (0.13, 2.67) 0.496
Too late 6.8% (n = 57) 7.7% (n = 33) 5.8% (n = 24) OR 0.74 (0.42, 1.29) 0.291
Insufficient informed about procedures at
home after discharge
6.5% (n = 55) 6.8% (n = 29) 6.3% (n = 26) OR 0.91 (0.52, 1.59) 0.735
Quality of life (QoL according to EQ-5D)
today
Any problems with mobility 48.2% (n = 405) 46.9% (n = 201) 49.5% (n = 204) OR 1.18 (0.89, 1.57) 0.254
Any problems with self-care 27.7% (n = 233) 25.2% (n = 108) 30.3% (n = 125) OR 1.30 (0.95, 1.79) 0.100
Any problems with usual activities 49.8% (n = 419) 50.8% (n = 218) 48.8% (n = 201) OR 0.92 (0.69, 1.22) 0.569
Any problems with pain/discomfort 50.1% (n = 421) 48.0% (n = 206) 52.2% (n = 215) OR 1.21 (0.91, 1.59) 0.186
Any problems with anxiety/depression 34.4% (n = 289) 34.7% (n = 149) 34.0% (n = 140) OR 0.96 (0.72, 1.29) 0.794
* Results are derived from generalised linear model (GLM) with a gamma distribution for LOS, logistic regression for binary outcomes and linear models for continuous
outcomes. **length of stay [days] ***chronic obstructive pulmonary disease
† models adjusted for the main predictors of LOS, namely age, gender, study centre, diagnosis and co-morbidities (anaemia, congestive heart failure, COPD, diabetes type
II, hypertension, coronary heart disease, renal insufficiency, malignancy, trauma).
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tients in tertiary referral centres. Fourth, the sample size
of patients may have been too low and trends may differ
looking at larger patient samples. Fifth, several circum-
stances may have created a selection bias. We included in-
patients exclusively during the first six months of 2011 und
2012 seeking to exclude seasonal confounders. However,
we cannot exclude that the second half of the years 2011
and 2012 may show different results. Furthermore, our
study population was selected in two study centres only.
Also, the questionnaire was written in German which might
have excluded patients not fluent enough in this language.
Sixth, the questionnaires were sent to the patients two to
four months after discharge and may therefore be subject
to recall bias. Also, some patients were hospitalised more
than once in other hospitals during the observation period
and may therefore have referred to the wrong hospitalisa-
tion. Seventh, we cannot exclude confounding by the fact
that the AP-DRG remuneration system was in place at one
study site in 2011 which might have mitigated the differen-
ce between the two study periods.
In conclusion the nation-wide implementation of Swis-
sDRG took place without major problems. Although our
study shows some limitations we observed some note-
worthy trends. We suggest further studies in order to mon-
itor these developments.
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Appendix 1: Questionnaire
Please download here the questionnaire in PDF format.
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Figures (large format)
Figure 1
Patient inclusion flow chart 2011.
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Figure 2
Patient inclusion flow chart 2012.
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